In summary, we now show that the combination of the two biomarkers TIMP2 and IGFBP7 seems to be highly predictive to identify patients who will develop moderate to severe AKI in the next 12–24 h following TAVI. The gene discussed is TIMP2; the disease is acute kidney injury.